8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
2018 / Randomized controlled trial
A randomized, double-blind, placebo-controlled trial evaluated d-allulose at 4 g or 7 g twice daily against sucralose in 121 Korean adults with BMI ≥ 23 kg/m². Body fat percentage and body fat mass decreased following allulose supplementation. Compared with placebo, the high-dose group demonstrated significant reductions in BMI along with total abdominal and subcutaneous fat areas on CT scans, with no differences in lipid profiles or nutrient intake.
Han Y, Kwon EY, Yu MK, et al. Nutrients, 2018. PMID 29385054
2018 / Open-label, non-randomized, controlled study
An open-label, non-randomized controlled study evaluated a 1-year continuous care intervention (CCI) delivering remote care, biometric feedback, and nutritional ketosis versus usual care (UC) in adults with type 2 diabetes. In the CCI group, HbA1c declined from 7.6 ± 0.09% to 6.3 ± 0.07%, weight decreased by 13.8 ± 0.71 kg, and non-metformin diabetes medication prescriptions fell from 56.9 ± 3.1% to 29.7 ± 3.0% (all P < 1.0 × 10^-16). Insulin was reduced or stopped in 94% of users, sulfonylureas were eliminated, and improvements were observed in HOMA-IR, hsCRP, and triglycerides, alongside a 10% increase in LDL-C; usual care participants had no significant biomarker or medication changes.
Hallberg SJ, McKenzie AL, Williams PT, et al. Diabetes Ther, 2018. PMID 29417495
2018 / Randomized controlled trial
Overweight or obese adults were randomized to an 8-week caloric restriction diet alone (CR, n = 15) or combined with sleep restriction on 5 nights per week (CR + SR, n = 21). Both groups had similar total weight, lean mass, and fat mass loss. However, the proportion of total mass lost as fat was significantly greater in the CR group (p = 0.016). Resting respiratory quotient decreased only in CR (p = 0.033), and fasting leptin concentration decreased only in CR + SR (p = 0.029).
Wang X, Sparks JR, Bowyer KP, et al. Sleep, 2018. PMID 29438540
2018 / Repeated-measures test-retest trial
Eleven participants completed two 24-hour fasts following a 3-day standardized weight-maintenance diet to evaluate test-retest reliability of hunger variables and subsequent energy intake. At 16 hours of fasting, ICCs for all hunger-related assessments were significant (r = 0.67-0.91; p ≤ 0.05), but reliability varied over time, with average ICCs of 0.81 for fullness, 0.74 for prospective food consumption (PFC), 0.67 for energy, 0.44 for desire to eat (DTE), and 0.36 for hunger. Average post-fast energy compensation was 60% of weight-maintenance needs (ranging 7 to 110%) and correlated with changes in PFC, hunger, and DTE, but not body fat percentage. After fasting, percent energy intake from fat and protein increased (29.9% to 37.3% and 13.8% to 16.8%), while carbohydrate intake decreased (56.4% to 46.0%).
Tinsley GM, Moore ML, Graybeal AJ Physiol Behav, 2018. PMID 29438660
2018 / Randomized controlled pilot study
An 8-week randomized controlled pilot study examined the impact of energy distribution timing within a hypocaloric, three-meal diet in 8 participants. Participants were assigned to either a Morning pattern (50%, 30%, and 20% of kcal at breakfast, lunch, and dinner) or an Evening pattern (20%, 30%, and 50% of kcal at breakfast, lunch, and dinner). Percent weight loss and regularity of sleep onset and wake times were significantly greater for Morning compared to Evening (p < 0.05). The authors note the need for longer studies in free-living participants with time-stamped dietary assessments.
Raynor HA, Li F, Cardoso C Physiol Behav, 2018. PMID 29471076
2018 / Randomized trial
Twenty-seven overweight or obese adults were randomized to intermittent energy restriction (IER, n=15) or continuous energy restriction (CER) until achieving 5% weight loss, followed by 7 days of weight stabilization. There was no significant difference in time to 5% weight loss (median 59 d vs 73 d, P=0.246) or body composition changes between groups. Neither diet significantly altered postprandial glycaemia (P=0.266), and insulinaemia was reduced comparatively (P=0.903). However, IER led to a significantly greater relative reduction in postprandial TAG responses (106 to 68 mmol×360 min/l) compared to CER (117 to 130 mmol×360 min/l; P=0.045), and a trend toward a greater reduction in C-peptide (P=0.057).
Antoni R, Johnston KL, Collins AL, et al. Br J Nutr, 2018. PMID 29508693
2018 / Randomized clinical trial (2x2 factorial)
A 2x2 factorial randomized trial assigned 92 functionally limited older men for 6 months to controlled diets of 0.8 or 1.3 g/kg/d of protein, paired with weekly testosterone or placebo. Changes in lean body mass (0.31 kg; 95% CI, -0.46 to 1.08 kg; P = .43), appendicular lean mass, muscle strength, physical function, and well-being did not differ between protein levels, regardless of testosterone use. However, fat mass decreased significantly more with higher protein intake compared to the RDA group (difference, -1.12 kg; 95% CI, -2.04 to -0.21; P = .02).
Bhasin S, Apovian CM, Travison TG, et al. JAMA Intern Med, 2018. PMID 29532075
2018 / Within-subject comparative study with washout
Ten patients with type 2 diabetes completed a 10-day supervised peri-operative-equivalent diet intervention, followed by a washout period, and then an identical diet paired with RYGB. Both interventions produced similar improvements in glucose levels, β-cell function, insulin sensitivity, and post-meal hepatic insulin resistance, alongside significant decreases in fasting and postprandial acyl ghrelin. The diet-only period led to greater improvements in basal hepatic glucose output and post-meal GIP secretion, whereas the diet plus RYGB intervention induced significantly greater increases in post-meal GLP-1, PYY, and glucagon levels.
Pop LM, Mari A, Zhao TJ, et al. Diabetes Obes Metab, 2018. PMID 29532631
2018 / Double-blind, crossover, randomized, placebo-controlled trial
In a randomized, double-blind crossover trial, 22 older adults with abdominal obesity underwent a 6-hour oral fat tolerance test after consuming either a supplement (200 mg resveratrol and 100 mg curcumin) or a placebo. Supplementation did not modify postprandial variations in circulating inflammatory markers (CRP, IL-6, IL-8, MCP-1) or adhesion molecules (sE-selectin, sVCAM-1, sICAM-1) compared to placebo (P Treatment×Time > 0.05). However, the supplement significantly reduced the cumulative postprandial response of sVCAM-1 (incremental area under the curve -4643%, P = 0.01), while whole-blood PPARA and NFKB1 gene expressions were unchanged.
Vors C, Couillard C, Paradis ME, et al. J Nutr, 2018. PMID 29546309
2018 / Double-blind, randomized crossover trial
A double-blind, randomized crossover trial evaluated the effects of 16 mg daily of TA-65 (an Astragalus membranaceus extract) versus placebo for 12 weeks with a 3-week washout in 40 patients with metabolic syndrome. Compared to placebo, TA-65 treatment led to significantly higher HDL-C and lower BMI, waist circumference, LDL/HDL ratio, and plasma TNF-alpha (p < 0.05 for all). Changes in HDL-C between periods were negatively correlated with changes in CRP (r = -0.511, p < 0.01), ALT (r = -0.61, p < 0.001), and TNF-alpha (r = -0.550, p < 0.001).
Fernandez ML, Thomas MS, Lemos BS, et al. Curr Pharm Des, 2018. PMID 29546832
2018 / Uncontrolled before-and-after intervention study
Participants in an outpatient cardiovascular clinic consumed a defined plant-based diet excluding all animal products and consisting of raw fruits, vegetables, seeds, and avocado for 4 weeks. Significant reductions were observed in systolic (-16.6 mmHg) and diastolic (-9.1 mmHg) blood pressure (P < 0.0005), serum lipids (P ≤ 0.008), and total medication usage (P < 0.0005). Reductions also occurred in weight (P < 0.0005), waist circumference (P < 0.0005), heart rate (P = 0.018), insulin (P < 0.0005), glycated hemoglobin (P = 0.002), and hs-CRP (P = 0.001).
Najjar RS, Moore CE, Montgomery BD Clin Cardiol, 2018. PMID 29575002
2018 / Randomized controlled trial
A randomized trial assigned 53 non-obese adults to either approximately 15% calorie restriction (n = 34) or a control group (n = 19) for two years. Participants in the restriction group lost an average of 8.7 kg, while control participants gained 1.8 kg. Measured daily energy expenditure was 80 to 120 kcal lower than predicted from weight loss, accompanied by decreased thyroid axis activity and lower F2-isoprostane levels.
Redman LM, Smith SR, Burton JH, et al. Cell Metab, 2018. PMID 29576535
2018 / Randomized controlled trial
Forty patients with Hashimoto's thyroiditis aged 22-50 were randomized to receive powdered Nigella sativa or placebo daily for 8 weeks. Treatment with Nigella sativa significantly reduced body weight and body mass index, decreased serum LDL and triglyceride concentrations, and significantly increased HDL cholesterol (P < 0.05), while no such changes were seen in the placebo group. Serum Nesfatin-1 was inversely associated with triglycerides (r = -0.31, P = 0.04).
Farhangi MA, Dehghan P, Tajmiri S Lipids Health Dis, 2018. PMID 29587770
2018 / Validation study using data from a 2-year trial
Researchers compared two mathematical models underlying web-based weight-loss prediction tools (NIH BWP and PBRC WLP) against data from the 2-year CALERIE study of calorie restriction. The PBRC WLP model simulated an exaggerated early drop in energy expenditure, substantially underestimating observed mean weight loss by 3.8 (95% CI: 3.5, 4.2) kg. In contrast, the NIH BWP model showed much closer alignment with data, having an overall mean ΔBW bias of -0.47 (-0.92, -0.015) kg. However, both models exhibited substantial variability in simulating individual outcomes.
Guo J, Brager DC, Hall KD Am J Clin Nutr, 2018. PMID 29635495
2018 / Crossover trial
Researchers evaluated the effect of a 45-minute aerobic exercise session performed either 17 hours prior (Prior Day Ex) or 40 minutes prior (Same Day Ex) versus no exercise on postprandial glucose control following a test meal in 11 normal weight and 12 overweight/obese adolescents. Across all trials, the overweight/obese group had higher fasting glucose (~6%) and insulin (~66%), and lower insulin sensitivity (~9%) than normal weight peers. Both Same Day Ex and Prior Day Ex reduced glucose area under the curve by 6% (P < .01), reduced insulin AUC by 15% and 13% respectively (P < .03), and increased insulin sensitivity by 8% and 6% respectively (P < .01). The magnitude of these effects did not differ between normal weight and overweight/obese groups.
Short KR, Pratt LV, Teague AM Pediatr Diabetes, 2018. PMID 29687558
2018 / Experimental crossover trial
This study evaluated 46 male and female participants aged 21-69 years who walked at natural paces for 15 minutes while chewing two gum pellets versus ingesting powder with the same ingredients excluding the gum base. Heart rates during walking and heart rate changes from rest significantly increased in the gum trial compared with the control trial. Male participants experienced significantly higher walking distance, speed, heart rate, and heart rate changes with gum chewing, while female participants showed significantly higher walking heart rate and heart rate changes. In male participants aged ≥40 years, walking distance, walking speed, steps, and energy expenditure were significantly increased in the gum trial compared with the control trial.
Hamada Y, Yanaoka T, Kashiwabara K, et al. J Phys Ther Sci, 2018. PMID 29706720
2018 / Single-blinded randomized controlled trial
In a single-blinded randomized controlled trial, 53 constipated patients with type 2 diabetes received either 10 g of flaxseed pre-mixed in cookies twice daily or placebo cookies for 12 weeks. Compared with placebo, the flaxseed group showed statistically significant improvements in absolute change for constipation symptom scores (2.46 vs. 0.41), weight (-3.8 vs. 0.0 kg), BMI (-1.5 vs. -0.1 kg/m2), FPG (-26.7 vs. -1.9 mg/dl), HbA1c (-0.8 vs. 1.0%), cholesterol (-37.3 vs. -10.4 mg/dl), LDLC (-21.0 vs. -4.3 mg/dl), and HDLC (4.7 vs. -4.4 mg/dl; all P < 0.05). Compliance was reported as good, and no adverse effects were observed.
Soltanian N, Janghorbani M Nutr Metab (Lond), 2018. PMID 29760761
2018 / Randomized controlled trial
In a 1-year randomized trial, 112 adults with abdominal obesity underwent 6 months of active weight loss followed by 6 months of maintenance. Average weight loss was 8.0 kg (SD 6.5) with intermittent restriction and 9.0 kg (SD 7.1) with continuous restriction (p = 0.6), and weight regain was similar (1.1 kg vs 0.4 kg). Both diets improved blood pressure, waist circumference, triglycerides, and HDL cholesterol equally, though the intermittent group reported higher hunger scores (4.7 vs 3.6, p = 0.002).
Sundfør TM, Svendsen M, Tonstad S Nutr Metab Cardiovasc Dis, 2018. PMID 29778565
2018 / Three-arm randomized controlled trial
Researchers randomized 191 adults who recently lost at least 5 kg to daily self-weighing and text feedback alone (control), combined with a lottery-based incentive, or combined with a direct incentive for 6 months, followed by 6 months of passive monitoring. Mean weight changes during the first 6 months were -3.0 kg for lottery, -2.8 kg for direct, and -1.4 kg for control (all pairwise comparisons p > 0.1). At 12 months, weight changes were -1.8 kg for lottery, -0.7 kg for direct, and -0.3 kg for control (p > 0.1). Across all arms, there were no significant differences in the proportion maintaining weight loss or in self-reported physical activity and eating behaviors.
Yancy WS, Shaw PA, Wesby L, et al. Nutr Diabetes, 2018. PMID 29795365
2018 / Randomized crossover trial
Nine obese women aged 22-31 years were tested under two randomly allocated conditions: a 2-day very low-calorie diet (511 kcal) and a 2-day usual diet. The calorie-restricted diet received a subjective stress rating of 41.5 ± 23.3, but had no detectable effects on heart rate variability indices, mood, grip strength, or psychomotor functions. However, calorie restriction significantly increased spatial processing and visuospatial working memory accuracy (p < 0.05) and decreased cognitive flexibility accuracy (p < 0.05).
Solianik R, Sujeta A, Čekanauskaitė A Exp Brain Res, 2018. PMID 29860630
2018 / Double-blind, placebo-controlled randomized trial
A double-blind, placebo-controlled trial evaluated a dietary supplement combining Lippia citriodora and Hibiscus sabdariffa polyphenolic extracts over 60 days in 54 overweight participants. Results showed improvements in anthropometric measurements, reductions in blood pressure and heart rate, and improved subjective health status. Furthermore, the extract combination increased the anorexigenic hormone glucagon-like peptide-1 and decreased the orexigenic hormone ghrelin.
Boix-Castejón M, Herranz-López M, Pérez Gago A, et al. Food Funct, 2018. PMID 29862395
2018 / Secondary analysis of two trials
Researchers analyzed self-reported food records from two trials of intermittent energy restriction (IER) in women (44 women for 6 months and 72 women for 4 months) to evaluate energy intake on unrestricted days. In both studies, reported energy intake on unrestricted days was 19% lower than the allocated isoenergetic diet, and 21% (Study 1) and 29% (Study 2) lower than baseline reported daily intakes, with similar reductions immediately before, after, and on other unrestricted days. Combined 3-month percentage weight loss was -5.8% (-6.7 to -4.7%) in those with consistent restriction days versus -7.4% (-8.7 to -6.2%) in the non-consistent group (p = .09). The authors noted that these findings need confirmation in larger groups, ideally using objective measures of energy balance.
Harvey J, Howell A, Morris J, et al. Food Sci Nutr, 2018. PMID 29876119
2018 / Randomized controlled trial
Thirty-six overweight-to-obese sedentary adults were randomized to exercise expending 300 or 600 kcal/session, 5 days/week for 12 weeks (1,500 vs. 3,000 kcal/week). The 3,000 kcal/week group significantly decreased percentage and kilograms of body fat (P < 0.01), whereas the 1,500 kcal/week group did not. The 1,500 and 3,000 kcal/week groups compensated for 943 (95% CI: -164 to 2,050) and 1,007 (95% CI: 32 to 1,982) kcal/week (62.9% and 33.6% of exercise energy expenditure, respectively; P >= 0.93 between groups). Resting metabolic rate and energy intake did not change, while food reinforcement and glucagon-like peptide-1 decreased (P < 0.02) and acylated ghrelin increased (P <= 0.02).
Flack KD, Ufholz K, Johnson L, et al. Am J Physiol Regul Integr Comp Physiol, 2018. PMID 29897822
2018 / Controlled pilot trial
Twelve CrossFit trainees were divided into a ketogenic diet group (n = 7) or a normal-diet control group (n = 5) for 12 weeks while continuing their training. Blood beta-hydroxybutyrate levels were 2.8- to 9.5-fold higher in the ketogenic group, confirming nutritional ketosis. In the ketogenic group, DXA fat mass decreased by 12.4% (p = 0.053), vastus lateralis thickness decreased by ~8% (p = 0.065), and dual-leg lean mass decreased by 1.4% (p = 0.068), while LDL cholesterol increased by ~35% (p = 0.048). No significant between-group differences were found for total lean body mass, fasting glucose, HDL cholesterol, triglycerides, resting energy expenditure, 1-RM back squat, 400 m run times, or VO2peak.
Kephart WC, Pledge CD, Roberson PA, et al. Sports (Basel), 2018. PMID 29910305